|
|
|
|
| LEADER |
04627nma a2201441 u 4500 |
| 001 |
EB002157307 |
| 003 |
EBX01000000000000001295422 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230515 ||| eng |
| 020 |
|
|
|a 9783036561622
|
| 020 |
|
|
|a books978-3-0365-6162-2
|
| 020 |
|
|
|a 9783036561615
|
| 100 |
1 |
|
|a Wang, Bin-Gui
|
| 245 |
0 |
0 |
|a Marine Natural Product Chemistry
|h Elektronische Ressource
|b A Themed Issue Dedicated to Prof. Dr. Peter Proksch on His Research Career
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2023
|
| 300 |
|
|
|a 1 electronic resource (306 p.)
|
| 653 |
|
|
|a cardiovascular diseases
|
| 653 |
|
|
|a COX-2 inhibition
|
| 653 |
|
|
|a marine sponge-derived fungus
|
| 653 |
|
|
|a apoptosis cells
|
| 653 |
|
|
|a drug delivery system
|
| 653 |
|
|
|a characteristic VOCs
|
| 653 |
|
|
|a α-glucosidase
|
| 653 |
|
|
|a antiproliferative activity
|
| 653 |
|
|
|a biphenyl ethers
|
| 653 |
|
|
|a Phomopsis sp.
|
| 653 |
|
|
|a sclerotiorin derivatives
|
| 653 |
|
|
|a polyketides
|
| 653 |
|
|
|a fungus
|
| 653 |
|
|
|a phenylhydrazone
|
| 653 |
|
|
|a AChE inhibitory
|
| 653 |
|
|
|a deep-sea actinomycetes
|
| 653 |
|
|
|a secondary metabolites
|
| 653 |
|
|
|a Penicillium oxalicum
|
| 653 |
|
|
|a illudalane sesquiterpenes
|
| 653 |
|
|
|a marine fungi
|
| 653 |
|
|
|a chemical structures
|
| 653 |
|
|
|a headspace solid phase microextraction
|
| 653 |
|
|
|a Research & information: general / bicssc
|
| 653 |
|
|
|a Neosartorya spinosa
|
| 653 |
|
|
|a anti-tumor
|
| 653 |
|
|
|a marine environment drug
|
| 653 |
|
|
|a deep-sea-derived fungus
|
| 653 |
|
|
|a thrombolytic activity
|
| 653 |
|
|
|a Trichocomaceae
|
| 653 |
|
|
|a bioactivity
|
| 653 |
|
|
|a mangrove endophytic fungi
|
| 653 |
|
|
|a Talaromyces sp.
|
| 653 |
|
|
|a Cochliobolus lunatus
|
| 653 |
|
|
|a quinazoline alkaloid
|
| 653 |
|
|
|a marine sponge-associated fungus
|
| 653 |
|
|
|a HT 29 colon cancer cells
|
| 653 |
|
|
|a anti-inflammatory activity
|
| 653 |
|
|
|a anthraquinones
|
| 653 |
|
|
|a Aspergillus nomius
|
| 653 |
|
|
|a chemotaxonomy
|
| 653 |
|
|
|a antimicrobial activity
|
| 653 |
|
|
|a quinazoline
|
| 653 |
|
|
|a cold seep
|
| 653 |
|
|
|a deep-sea fungi
|
| 653 |
|
|
|a cytotoxic activity
|
| 653 |
|
|
|a fibrinolytic enzymes
|
| 653 |
|
|
|a Aspergillus versicolor
|
| 653 |
|
|
|a natural compounds
|
| 653 |
|
|
|a deep sea
|
| 653 |
|
|
|a molecular networking
|
| 653 |
|
|
|a oxisterigmatocystin
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a natural products
|
| 653 |
|
|
|a seaweeds
|
| 653 |
|
|
|a polyketide
|
| 653 |
|
|
|a volatile organic compounds
|
| 653 |
|
|
|a deep-sea
|
| 653 |
|
|
|a antioxidant activity
|
| 653 |
|
|
|a anti-food allergy
|
| 653 |
|
|
|a Penicillium cyclopium
|
| 653 |
|
|
|a marine sediment-derived fungus
|
| 653 |
|
|
|a molecular docking
|
| 653 |
|
|
|a marine polysaccharide
|
| 653 |
|
|
|a mangrove endophytic fungus
|
| 653 |
|
|
|a biomedical utilization
|
| 653 |
|
|
|a immunosuppressive activity
|
| 653 |
|
|
|a anticancer
|
| 653 |
|
|
|a marine fungus
|
| 653 |
|
|
|a mechanisms of action
|
| 653 |
|
|
|a nanocarrier
|
| 653 |
|
|
|a antibacterial activity
|
| 653 |
|
|
|a sambutoxin
|
| 653 |
|
|
|a Penicillium solitum
|
| 653 |
|
|
|a polyketide derivatives
|
| 653 |
|
|
|a marine bacteria
|
| 653 |
|
|
|a absolute configurations
|
| 653 |
|
|
|a Neopetrosia chaliniformis
|
| 653 |
|
|
|a Diaporthe sp.
|
| 653 |
|
|
|a lipopeptides
|
| 653 |
|
|
|a zebrafish toxicity
|
| 653 |
|
|
|a marine microorganisms
|
| 653 |
|
|
|a cancer therapy
|
| 653 |
|
|
|a Aspergillus oryzae
|
| 653 |
|
|
|a biological activities
|
| 653 |
|
|
|a diketopiperazines
|
| 653 |
|
|
|a phthalide
|
| 653 |
|
|
|a chromenones
|
| 653 |
|
|
|a anti-tyrosinase
|
| 653 |
|
|
|a co-culture
|
| 653 |
|
|
|a antibiofilm activity
|
| 653 |
|
|
|a Chemistry / bicssc
|
| 700 |
1 |
|
|a Edrada-Ebel, RuAngelie
|
| 700 |
1 |
|
|a Wang, Chang-Yun
|
| 700 |
1 |
|
|a Wang, Bin-Gui
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 028 |
5 |
0 |
|a 10.3390/books978-3-0365-6162-2
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/96630
|z DOAB: description of the publication
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/6575
|7 0
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 363
|
| 082 |
0 |
|
|a 000
|
| 082 |
0 |
|
|a 540
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 700
|
| 520 |
|
|
|a Marine Drugs is very pleased to host a Special Issue in honour of Prof. Dr. Peter Proksch, who served as Editor in Chief for Marine Drugs from 2005 to 2009, for his excellent research contribution.
|